Literature DB >> 8069654

A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene.

M Zeviani1, F Muntoni, N Savarese, G Serra, V Tiranti, F Carrara, C Mariotti, S DiDonato.   

Abstract

Several members of a three-generation kindred from Sardinia were affected by a maternally inherited syndrome characterized by features of both myoclonus epilepsy with ragged-red fibers (MERRF) and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). Clinically, symptoms such as myoclonus epilepsy, neural deafness and ataxia were variably associated with stroke-like episodes and/or migrainous attacks. Morphologically, numerous MELAS-associated SDH-stained vessels were observed in muscle biopsies, either alone or in combination with ragged-red fibers, the morphological hallmark of MERRF. Sequence analysis of the mtDNA tRNA genes revealed the presence of a single, heteroplasmic T-->C transition at nt 8356, in the region of the tRNA(Lys) gene corresponding to the T-psi-C stem. The T-->C(8356) transition was exclusively found in the maternal lineage of our family, and the relative amount of the mutant mtDNA species in muscle was correlated with the severity of the clinical presentation. Therefore, we propose that the T-->C(8356) transition is responsible for the mitochondrial encephalomyopathy found in our family, and must be added to the expanding list of the pathogenetically relevant mutations of human mtDNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8069654     DOI: 10.1159/000472390

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  29 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

2.  Fatal cerebral hemorrhage in mitochondrial encephalomyopathy. Clinical and pathological data of a case.

Authors:  Haruhisa Kato; Masanobu Uchigata; Mutsumi Iijima; Seiichiro Shimizu; Ikuya Nonaka; Yuichi Goto
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

3.  A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes.

Authors:  Ioannis Zaganas; Helen Latsoudis; Eufrosini Papadaki; Pelagia Vorgia; Martha Spilioti; Andreas Plaitakis
Journal:  J Neurol       Date:  2009-02-27       Impact factor: 4.849

Review 4.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

5.  The T-C(8356) mitochondrial DNA mutation in a Japanese family.

Authors:  M Sano; M Ozawa; S Shiota; Y Momose; M Uchigata; Y Goto
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

Review 6.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 7.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

8.  MERRF/MELAS overlap syndrome due to the m.3291T>C mutation.

Authors:  Kaiming Liu; Hui Zhao; Kunqian Ji; Chuanzhu Yan
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

9.  Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene.

Authors:  F C Mansergh; S Millington-Ward; A Kennan; A S Kiang; M Humphries; G J Farrar; P Humphries; P F Kenna
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

10.  Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA).

Authors:  Yelena Bykhovskaya; Kari Casas; Emebet Mengesha; Aida Inbal; Nathan Fischel-Ghodsian
Journal:  Am J Hum Genet       Date:  2004-04-22       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.